GAFFI Board and executives meeting in Lausanne - first in person meeting for >2 years. Looking forward to the release of GAFFI/Africa CDC Diagnostic survey and #WHO Fungal Pathogen Priority List. So much still to do to accomplish full diagnostic and antifungal access.
A new study from Brazil showing a prevalence of chronic pulmonary #aspergillosis >10% in patients previously treated for #TB. Haemoptysis is an important clue. #CPA
https://t.co/9ow05P5nxS
One of our PhD students, Dr Samuel Fayemiwo (@DFayemiwo ) ready to answer questions about his work in Nigeria: RVVC - behavioural factors and vulval symptoms, supervised by our Head of Service, Dr Riina Richardson (@RiinaRichardson)
#timm21 If you enjoyed this morning's excellent RVVC session, check out poster 185 by @RiinaRichardson and her PhD student @DFayemiwo, with lab work done at @MycologyRefManc
Did you know? RVVC is much more prevalent in Nigeria than the UK (but regions vary)
@MMSNIG@UniIbadan
Paul Bowyer starts us off looking at the lung mycobiome in health and disease NGS give us a population snapshot (with all the caveats of NGS) it is not a quantitative technique that can (currently) be used clinically #TIMM2021